Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells

Biochimica et Biophysica Acta - General Subjects

Volumn 1820, Issue 2, 2012, Pages 104-115

  Hsu, Ya Fen ^a,b   Sheu, Joen Rong ^c   Lin, Chien Huang ^c   Yang, De Shin ^c   Hsiao, George ^c   Ou, George ^c   Chiu, Pei Ting ^c   Huang, Yu Han ^c   Kuo, Wen Hsin ^c   Hsu, Ming Jen ^c  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b Landseed Hospital   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Colon cancer; Histone deacetylase; Sirtinol; Survivin; Trichostatin A

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; SIRTINOL; SURVIVIN; TRICHOSTATIN A;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL PROLIFERATION; CELL VIABILITY; CHROMATIN IMMUNOPRECIPITATION; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION;

AMP-ACTIVATED PROTEIN KINASES; APOPTOSIS; BENZAMIDES; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HT29 CELLS; HUMANS; HYDROXAMIC ACIDS; INHIBITOR OF APOPTOSIS PROTEINS; LUCIFERASES; NAPHTHOLS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLICAMYCIN; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 83455246811     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2011.11.011     Document Type: Article

References (47)

1. J.E. Bolden, M.J. Peart, and R.W. Johnstone Anticancer activities of histone deacetylase inhibitors Nat. Rev. Drug Discov. 5 2006 769 784 (Pubitemid 44348499)
2. M. Porcu, and A. Chiarugi The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension Trends Pharmacol. Sci. 26 2005 94 103 (Pubitemid 40170172)
3. M. Krishnan, A.B. Singh, J.J. Smith, A. Sharma, X. Chen, S. Eschrich, T.J. Yeatman, R.D. Beauchamp, and P. Dhawan HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability Oncogene 29 2010 305 312
4. S. Minucci, and P.G. Pelicci Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer Nat. Rev. Cancer 6 2006 38 51 (Pubitemid 43054973)
5. S. Cory, and J.M. Adams The Bcl2 family: regulators of the cellular life-or-death switch Nat. Rev. Cancer 2 2002 647 656 (Pubitemid 37328916)
6. S.M. Srinivasula, and J.D. Ashwell IAPs: what's in a name? Mol. Cell. 30 2008 123 135 (Pubitemid 351626688)
7. D.C. Altieri Survivin, cancer networks and pathway-directed drug discovery Nat. Rev. Cancer 8 2008 61 70
8. G. Ambrosini, C. Adida, and D.C. Altieri A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma Nat. Med. 3 1997 917 921 (Pubitemid 27353455)
9. H. Kawasaki, D.C. Altieri, C.D. Lu, M. Toyoda, T. Tenjo, and N. Tanigawa Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer Cancer Res. 58 1998 5071 5074 (Pubitemid 28521163)
10. S. Mehrotra, L.R. Languino, C.M. Raskett, A.M. Mercurio, T. Dohi, and D.C. Altieri IAP regulation of metastasis Cancer Cell 17 2010 53 64
11. C.W. Lee, C.M. Raskett, I. Prudovsky, and D.C. Altieri Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis Cancer Res. 68 2008 5273 5281
12. K. Shirai, Y. Suzuki, K. Oka, S.E. Noda, H. Katoh, J. Itoh, H. Itoh, S. Ishiuchi, H. Sakurai, M. Hasegawa, and T. Nakano Nuclear survivin expression predicts poorer prognosis in glioblastoma J. Neurooncol. 91 2009 353 358
13. M.V. Mityaev, E.P. Kopantzev, A.A. Buzdin, T.V. Vinogradova, and E.D. Sverdlov Functional significance of a putative sp1 transcription factor binding site in the survivin gene promoter Biochemistry (Mosc) 73 2008 1183 1191
14. D. Grossman, P.J. Kim, O.P. Blanc-Brude, D.E. Brash, S. Tognin, P.C. Marchisio, and D.C. Altieri Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53 J. Clin. Invest. 108 2001 991 999 (Pubitemid 32946073)
15. A. Mirza, M. McGuirk, T.N. Hockenberry, Q. Wu, H. Ashar, S. Black, S.F. Wen, L. Wang, P. Kirschmeier, W.R. Bishop, L.L. Nielsen, C.B. Pickett, and S. Liu Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway Oncogene 21 2002 2613 2622 (Pubitemid 34478319)
16. D.G. Hardie, and D. Carling The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur. J. Biochem. 246 1997 259 273 (Pubitemid 27232500)
17. K. Inoki, T. Zhu, and K.L. Guan TSC2 mediates cellular energy response to control cell growth and survival Cell 115 2003 577 590 (Pubitemid 37506046)
18. M. Garcia-Gil, R. Pesi, S. Perna, S. Allegrini, M. Giannecchini, M. Camici, and M.G. Tozzi 5′-aminoimidazole-4-carboxamide riboside induces apoptosis in human neuroblastoma cells Neuroscience 117 2003 811 820 (Pubitemid 36332300)
19. D. Guo, I.J. Hildebrandt, R.M. Prins, H. Soto, M.M. Mazzotta, J. Dang, J. Czernin, J.Y. Shyy, A.D. Watson, M. Phelps, C.G. Radu, T.F. Cloughesy, and P.S. Mischel The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis Proc. Natl. Acad. Sci. U. S. A. 106 2009 12932 12937
20. R.Y. Su, Y. Chao, T.Y. Chen, D.Y. Huang, and W.W. Lin 5-Aminoimidazole-4-carboxamide riboside sensitizes TRAIL- and TNF {alpha}-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling Mol. Cancer Ther. 6 2007 1562 1571 (Pubitemid 46954023)
21. R. Rattan, S. Giri, A.K. Singh, and I. Singh 5-Aminoimidazole-4- carboxamide-1-beta-D-ribofuranoside inhibits cancer cell proliferation in vitro and in vivo via AMP-activated protein kinase J. Biol. Chem. 280 2005 39582 39593 (Pubitemid 41713917)
22. S. Emiliani, W. Fischle, C. Van Lint, Y. Al-Abed, and E. Verdin Characterization of a human RPD3 ortholog, HDAC3 Proc. Natl. Acad. Sci. U. S. A. 95 1998 2795 2800 (Pubitemid 28135808)
23. M.J. Hsu, C.Y. Hsu, B.C. Chen, M.C. Chen, G. Ou, and C.H. Lin Apoptosis signal-regulating kinase 1 in amyloid beta peptide-induced cerebral endothelial cell apoptosis J. Neurosci. 27 2007 5719 5729 (Pubitemid 350021089)
24. C.T. Kuo, M.J. Hsu, B.C. Chen, C.C. Chen, C.M. Teng, S.L. Pan, and C.H. Lin Denbinobin induces apoptosis in human lung adenocarcinoma cells via Akt inactivation, bad activation, and mitochondrial dysfunction Toxicol. Lett. 177 2008 48 58
25. M.J. Hsu, C.K. Chang, M.C. Chen, B.C. Chen, H.P. Ma, C.Y. Hong, and C.H. Lin Apoptosis signal-regulating kinase 1 in peptidoglycan-induced COX-2 expression in macrophages J. Leukoc. Biol. 87 2010 1069 1082
26. E.J. Noh, D.S. Lim, G. Jeong, and J.S. Lee An HDAC inhibitor, trichostatin A, induces a delay at G2/M transition, slippage of spindle checkpoint, and cell death in a transcription-dependent manner Biochem. Biophys. Res. Commun. 378 2009 326 331
27. F. Li, and D.C. Altieri The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression Cancer Res. 59 1999 3143 3151 (Pubitemid 29316014)
28. J.C. Bourdon, K. Fernandes, F. Murray-Zmijewski, G. Liu, A. Diot, D.P. Xirodimas, M.K. Saville, and D.P. Lane p53 isoforms can regulate p53 transcriptional activity Genes Dev. 19 2005 2122 2137 (Pubitemid 41330315)
29. Y.F. Hsu, J.R. Sheu, G. Hsiao, C.H. Lin, T.H. Chang, P.T. Chiu, C.Y. Wang, and M.J. Hsu p53 in trichostatin A induced C6 glioma cell death Biochim. Biophys. Acta 1810 2011 504 513
30. C.A. Godman, R. Joshi, B.R. Tierney, E. Greenspan, T.P. Rasmussen, H.W. Wang, D.G. Shin, D.W. Rosenberg, and C. Giardina HDAC3 impacts multiple oncogenic pathways in colon cancer cells with effects on Wnt and vitamin D signaling Cancer Biol. Ther. 7 2008 1570 1580
31. O. Gressner, T. Schilling, K. Lorenz, E. Schulze Schleithoff, A. Koch, H. Schulze-Bergkamen, A.M. Lena, E. Candi, A. Terrinoni, M.V. Catani, M. Oren, G. Melino, P.H. Krammer, W. Stremmel, and M. Muller TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria EMBO J. 24 2005 2458 2471 (Pubitemid 41032596)
32. I. Katoh, K.I. Aisaki, S.I. Kurata, S. Ikawa, and Y. Ikawa p51A (TAp63gamma), a p53 homolog, accumulates in response to DNA damage for cell regulation Oncogene 19 2000 3126 3130 (Pubitemid 30438471)
33. A.M. Bode, and Z. Dong Post-translational modification of p53 in tumorigenesis Nat. Rev. Cancer 4 2004 793 805 (Pubitemid 39331151)
34. C.L. Brooks, and W. Gu Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation Curr. Opin. Cell Biol. 15 2003 164 171 (Pubitemid 36332191)
35. D. Hu, S. Liu, L. Shi, C. Li, L. Wu, and Z. Fan Cleavage of survivin by Granzyme M triggers degradation of the survivin-XIAP complex to free caspase activity leading to cytolysis of target tumor cells J. Biol. Chem. 285 2010 18326 18335
36. P. Wu, Y. Tian, G. Chen, B. Wang, L. Gui, L. Xi, X. Ma, Y. Fang, T. Zhu, D. Wang, L. Meng, G. Xu, S. Wang, D. Ma, and J. Zhou Ubiquitin B: an essential mediator of trichostatin A-induced tumor-selective killing in human cancer cells Cell Death Differ. 17 2010 109 118
37. X.H. Zhang, M. Rao, J.A. Loprieato, J.A. Hong, M. Zhao, G.Z. Chen, A.E. Humphries, D.M. Nguyen, J.B. Trepel, X. Yu, and D.S. Schrump Aurora A, Aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer Cancer Biol. Ther. 7 2008 1388 1397
38. N.K. Sah, A. Munshi, M. Hobbs, B.Z. Carter, M. Andreeff, and R.E. Meyn Effect of downregulation of survivin expression on radiosensitivity of human epidermoid carcinoma cells Int. J. Radiat. Oncol. Biol. Phys. 66 2006 852 859 (Pubitemid 44436718)
39. A.N. Ma, J. Lu, X.J. Zhou, and Y.X. Wang Histone deacetylation directs DNA methylation in survivin gene silencing Biochem. Biophys. Res. Commun. 404 2011 268 272
40. J.Y. Fang, Y.X. Chen, J. Lu, R. Lu, L. Yang, H.Y. Zhu, W.Q. Gu, and L.G. Lu Epigenetic modification regulates both expression of tumor-associated genes and cell cycle progressing in human colon cancer cell lines: colo-320 and SW1116 Cell Res. 14 2004 217 226 (Pubitemid 43231819)
41. X. Huang, and B. Guo Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells Cancer Res. 66 2006 9245 9251 (Pubitemid 44521146)
42. W. Weichert, A. Roske, S. Niesporek, A. Noske, A.C. Buckendahl, M. Dietel, V. Gekeler, M. Boehm, T. Beckers, and C. Denkert Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo Clin. Cancer Res. 14 2008 1669 1677 (Pubitemid 351469450)
43. W. Weichert, A. Roske, V. Gekeler, T. Beckers, C. Stephan, K. Jung, F.R. Fritzsche, S. Niesporek, C. Denkert, M. Dietel, and G. Kristiansen Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy Br. J. Cancer 98 2008 604 610 (Pubitemid 351214528)
44. Y. Li, X. Li, and B. Guo Chemopreventive agent 3,3′- diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases Cancer Res. 70 2010 646 654
45. H. Ota, E. Tokunaga, K. Chang, M. Hikasa, K. Iijima, M. Eto, K. Kozaki, M. Akishita, Y. Ouchi, and M. Kaneki Sirt1 inhibitor, sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells Oncogene 25 2006 176 185 (Pubitemid 43083679)
46. Y.C. Hsu, X. Meng, L. Ou, and M.M. Ip Activation of the AMP-activated protein kinase-p38 MAP kinase pathway mediates apoptosis induced by conjugated linoleic acid in p53-mutant mouse mammary tumor cells Cell. Signal. 22 2010 590 599
47. A. Puissant, and P. Auberger AMPK- and p62/SQSTM1-dependent autophagy mediate resveratrol-induced cell death in chronic myelogenous leukemia Autophagy 6 2010 655 657